MORRISTOWN, N.J. — Actavis has launched its version of an epilepsy drug made by UCB. The generic drug maker said it received approval from the Food and Drug Administration for levetiracetam ...

BRUSSELS (Reuters) - Belgian pharma group UCB said on Monday that U.S. health authorities had approved epilepsy drug Keppra XR and that it would go on sale just before its mother drug loses patent ...

A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk ...